Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (21-30 of 328) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapyGiulia Morsica, Sabrina Bagaglio, Caterina Uberti-Foppa, et al.
AIDS (London, England)|May 16, 2007
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2Simona Bossolasco, Silvia Nozza, Giovanni Gaiera, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2006
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapyCaterina Sagnelli, Luca Fumagalli, Anna Prigitano, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 24, 2016
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in ItalyUmberto Restelli, Alfredo Alberti, Adriano Lazzarin, et al.
The New Microbiologica|December 18, 2007
Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cellsPriscilla Biswas, Andrea Vecchi, Paola Mantegani, et al.
Journal of Neurovirology|December 20, 2002
Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an updatePaola Cinque, Simona Bossolasco, Arabella Bestetti, et al.
The New Microbiologica|February 26, 2013
Management of HIV infection after triple class failureFrancesca Cossarini, Vincenzo Spagnuolo, Nicola Gianotti, et al.
European Journal of Immunology|October 28, 2003
CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytesPriscilla Biswas, Barbara Mantelli, Fanny Delfanti, et al.
Journal of Clinical Microbiology|August 7, 2004
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infectionPaolo Scarpellini, Silvana Tasca, Laura Galli, et al.
AIDS (London, England)|March 3, 2006
A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresisHamid Hasson, Silvia Nozza, Barbara Mantelli, et al.
Pageof 33

Showing results (21-30 of 328) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2009
Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapyGiulia Morsica, Sabrina Bagaglio, Caterina Uberti-Foppa, et al.
AIDS (London, England)|May 16, 2007
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2Simona Bossolasco, Silvia Nozza, Giovanni Gaiera, et al.
The Journal of Antimicrobial Chemotherapy|February 14, 2006
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapyCaterina Sagnelli, Luca Fumagalli, Anna Prigitano, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 24, 2016
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in ItalyUmberto Restelli, Alfredo Alberti, Adriano Lazzarin, et al.
The New Microbiologica|December 18, 2007
Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cellsPriscilla Biswas, Andrea Vecchi, Paola Mantegani, et al.
Journal of Neurovirology|December 20, 2002
Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an updatePaola Cinque, Simona Bossolasco, Arabella Bestetti, et al.
The New Microbiologica|February 26, 2013
Management of HIV infection after triple class failureFrancesca Cossarini, Vincenzo Spagnuolo, Nicola Gianotti, et al.
European Journal of Immunology|October 28, 2003
CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytesPriscilla Biswas, Barbara Mantelli, Fanny Delfanti, et al.
Journal of Clinical Microbiology|August 7, 2004
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infectionPaolo Scarpellini, Silvana Tasca, Laura Galli, et al.
AIDS (London, England)|March 3, 2006
A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresisHamid Hasson, Silvia Nozza, Barbara Mantelli, et al.
Pageof 33